Scientists test new dengue shot on people with varied immunity
NCT ID NCT05691530
Summary
This early-stage study is testing a potential new vaccine against dengue, a serious mosquito-borne illness. It aims to see if the vaccine is safe and how well it works in healthy adults who have never had dengue, have had it once, or have had it multiple times. Researchers will closely monitor participants' health and immune responses over several months to understand how prior dengue exposure affects the vaccine.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPONSE TO DENGUE EXPOSURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.